<unk> (tablet) is an antinauseant and antiemetic agent that is FDA approved for the prevention of nausea and vomiting associated with:1) initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin;2) radiation, including total body irradiation and fractionated abdominal radiation.   Common adverse reactions include asthenia, headache, somnolence, and fever.
Granisetron 
Tropisetron
Lerisetron
Ramosetron
Alosetron
Dolastetron 
Cilansetron
Palonosetron